| Financial Year |
March 31 2023 |
| Monetary Funds |
279,439,277.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
115,959,786.74 |
| Advances to Suppliers |
33,139,355.23 |
| Other Receivables |
1,393,911.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
348,678,283.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,152,064.04 |
| Total Current Assets |
894,173,502.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,517,825,395.43 |
| Under-construction Projects |
134,177,451.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,634,920.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
39,284,514.80 |
| Deferred Income Tax Assets |
66,161,456.34 |
| Other Non-Current Assets |
5,026,099.89 |
| Sub-Total of Non-Current Assets |
1,916,943,104.70 |
| Total Assets |
2,811,116,607.58 |
| Short-Term Loans |
988,686,807.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
75,575,840.19 |
| Accounts Payable |
210,797,514.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,814,928.34 |
| Taxes Payable |
11,870,710.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
79,661.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
100,559,281.97 |
| Other Current Liabilities |
25,559,811.81 |
| Sub-Total of Current Liabilities |
1,507,997,701.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
891,858.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,172,015.28 |
| Total Liabilities |
1,551,169,716.93 |
| Paid-In Capital(Or Share Stock) |
162,943,082.00 |
| Capital Surplus |
625,963,166.99 |
| Surplus Reserve |
43,723,157.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
370,723,007.50 |
| Minority Stockholder's Interest |
41,712,121.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,218,234,769.36 |
| Owner's Equity（Stockholder's Equity） |
1,259,946,890.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,811,116,607.58 |
